Challenges in accurate quantitation of lysophosphatidic acids in human biofluids

Journal of Lipid Research

Volumn 55, Issue 8, 2014, Pages 1784-1796

  Onorato, Joelle M ^a   Shipkova, Petia ^a   Minnich, Anne ^a   Aubry, Anne Françoise ^a   Easter, John ^a   Tymiak, Adrienne ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Bronchoalveolar lavage fluid; Human plasma; Idiopathic pulmonary fibrosis; Stability

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID;

ARTICLE; BODY FLUID; CASE REPORT; CONTROLLED STUDY; FIBROSING ALVEOLITIS; FREEZE THAWING; HUMAN; ISOTOPE LABELING; LIMIT OF QUANTITATION; LIPID BLOOD LEVEL; LIQUID CHROMATOGRAPHY; LUNG FLUID; MEASUREMENT ACCURACY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; CLINICAL TRIAL; FEMALE; MALE; MASS SPECTROMETRY; METABOLISM; PROCEDURES;

BRONCHOALVEOLAR LAVAGE FLUID; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LYSOPHOSPHOLIPIDS; MALE; MASS SPECTROMETRY;

EID: 84905030190     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D050070     Document Type: Article

References (36)

1. Gardell, S. E., A. E. Dubin, and J. Chun. 2006. Emerging medicinal roles for lysophospholipid signaling. Trends Mol. Med. 12: 65-75. (Pubitemid 43202124)
2. Pradère, J. P., J. Klein, S. Gres, C. Guigne, E. Neau, P. Valet, D. Calise, J. Chun, J. L. Bascands, J. S. Saulnier-Blache, et al. 2007. LPA1 receptor activation promotes renal interstitial fibrosis. J. Am. Soc. Nephrol. 18: 3110-3118. (Pubitemid 350223970)
3. Tager, A. M., P. LaCamera, B. S. Shea, G. S. Campanella, M. Selman, Z. Zhao, V. Polosukhin, J. Wain, B. A. Karimi-Shah, N. D. Kim, et al. 2008. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14: 45-54.
4. Tigyi, G. 2010. Aiming drug discovery at lysophosphatidic acid targets. Br. J. Pharmacol. 161: 241-270.
5. Lin, M. E., D. R. Herr, and J. Chun. 2010. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 91: 130-138.
6. Ley, B., H. R. Collard, and T. E. King, Jr. 2011. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183: 431-440.
7. Jesionowska, A., E. Cecerska, and B. Dolegowska, B. 2014. Methods for quantifying lysophosphatidic acid in biofluids: a review. Anal. Biochem. 453: 38-43.
8. Smyth, S. S., H. Y. Cheng, S. Miriyala, M. Panchatcharam, and A. J. Morris. 2008. Roles of lysophosphatidic acid in cardiovascular physiology and disease. Biochim. Biophys. Acta. 1781: 563-570.
9. Kishimoto, T., T. Matsuoka, S. Imamura, and K. Mizuno. 2003. A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. Clin. Chim. Acta. 333: 59-67. (Pubitemid 36694827)
10. Saulnier-Blache, J. S., A. Girard, M. F. Simon, M. Lafontan, and P. Valet. 2000. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J. Lipid Res. 41: 1947-1951. (Pubitemid 32038989)
11. Baker, D. L., D. M. Desiderio, D. D. Miller, B. Tolley, and G. J. Tigyi. 2001. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal. Biochem. 292: 287-295.
12. Yoon, H. R., H. Kim, and S. H. Cho. 2003. Quantitative analysis of acyl-lysophosphatidic acid in plasma using negative ionization tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 788: 85-92. (Pubitemid 36369113)
13. Murph, M., T. Tanaka, J. Pang, E. Felix, S. Liu, R. Trost, A. K. Godwin, R. Newman, and G. Mills. 2007. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. Methods Enzymol. 433: 1-25.
14. Shan, L., K. Jaffe, S. Li, and L. Davis. 2008. Quantitative determination of lysophosphatidic acid by LC/ESI/MS/MS employing a reversed phase HPLC column. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 864: 22-28.
15. Sutphen, R., Y. Xu, G. D. Wilbanks, J. Fiorica, E. C. Grendys, Jr., J. P. LaPolla, H. Arango, M. S. Hoffman, M. Martino, K. Wakeley, et al. 2004. Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 13: 1185-1191. (Pubitemid 38917907)
16. Liebisch, G., and M. Scherer. 2012. Quantification of bioactive sphingo- and glycerophospholipid species by electrospray ionization tandem mass spectrometry in blood. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883-884: 141-146.
17. Baker, D. L., P. Morrison, B. Miller, C. A. Riely, B. Tolley, A. M. Westermann, J. M. Bonfrer, E. Bais, W. H. Moolenaar, and G. Tigyi. 2002. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA. 287: 3081-3082. (Pubitemid 34633980)
18. Georas, S. N., E. Berdyshev, W. Hubbard, I. A. Gorshkova, P. V. Usatyuk, B. Saatian, A. C. Myers, M. A. Williams, H. Q. Xiao, M. Liu, et al. 2007. Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin. Exp. Allergy. 37: 311-322. (Pubitemid 46393233)
19. Park, G. Y., Y. G. Lee, E. Berdyshev, S. Nyenhuis, J. Du, P. Fu, I. A. Gorshkova, Y. Li, S. Chung, M. Karpurapu, et al. 2013. Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am. J. Respir. Crit. Care Med. 188: 928-940.
20. Zhao, Z., and Y. Xu. 2009. Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires preseparation of lysophosphatidylcholine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 3739-3742.
21. Tokumura, A., E. Majima, Y. Kariya, K. Tominaga, K. Kogure, K. Yasuda, and K. Fukuzawa. 2002. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277: 39436-39442. (Pubitemid 35190918)
22. Aoki, J., A. Inoue, and S. Okudaira. 2008. Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta. 1781: 513-518.
23. Okudaira, S., H. Yukiura, and J. Aoki. 2010. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie. 92: 698-706.
24. Aoki, J., A. Taira, Y. Takanezawa, Y. Kishi, K. Hama, T. Kishimoto, K. Mizuno, K. Saku, R. Taguchi, and H. Arai. 2002. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 277: 48737-48744. (Pubitemid 35470839)
25. Nakamura, K., R. Ohkawa, S. Okubo, M. Tozuka, M. Okada, S. Aoki, J. Aoki, H. Arai, H. Ikeda, and Y. Yatomi. 2007. Measurement of lysophospholipase D/autotaxin activity in human serum samples. Clin. Biochem. 40: 274-277. (Pubitemid 46108705)
26. Scherer, M., G. Schmitz, and G. Liebisch. 2009. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clin. Chem. 55: 1218-1222.
27. Zhao, Y., J. Tong, D. He, S. Pendyala, B. Evgeny, J. Chun, A. I. Sperling, and V. Natarajan. 2009. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir. Res. 10: 114.
28. Kim, H., H-R. Yoon, and D. Pyo. 2002. Quantitative analysis of lysophosphatic acid in human plasma by tandem mass spectrometry. Bull. Korean Chem. Soc. 23: 1139-1143.
29. Wang, J., M. Sibrian-Vazquez, J. O. Escobedo, M. Lowry, L. Wang, Y. H. Chu, R. G. Moore, and R. M. Strongin. 2013. Simple enrichment and analysis of plasma lysophosphatidic acids. Analyst. 138: 6852-6859.
30. Das, A. K., J. E. Milam, R. C. Reddy, and A. K. Hajra. 2006. Facile syntheses of acyl dihydroxyacetone phosphates and lysophosphatidic acids having different acyl groups. J. Lipid Res. 47: 1874-1880. (Pubitemid 44222839)
31. Koivusalo, M., P. Haimi, L. Heikinheimo, R. Kostiainen, and P. Somerharju. 2001. Quantitative determination of phospholipid compositions by ESI-MS: effects of acyl chain length, unsaturation, and lipid concentration on instrument response. J. Lipid Res. 42: 663-672. (Pubitemid 32367010)
32. Montesi, S. B., S. K. Mathai, L. N. Brenner, I. A. Gorshkova, E. V. Berdyshev, A. M. Tager, and B. S. Shea. 2014. Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis. BMC Pulm. Med. 14: 5.
33. Zacarias, A., D. Bolanowski, and A. Bhatnagar. 2002. Comparative measurements of multicomponent phospholipid mixtures by electrospray mass spectroscopy: relating ion intensity to concentration. Anal. Biochem. 308: 152-159. (Pubitemid 35191648)
34. Wishart, D. S., T. Jewison, A. C. Guo, M. Wilson, C. Knox, Y. Liu, Y. Djoumbou, R. Mandal, F. Aziat, E. Dong, et al. 2013. HMDB 3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res. 41: D801-D807.
35. Wishart, D. S., C. Knox, A. C. Guo, R. Eisner, N. Young, B. Gautam, D. D. Hau, N. Psychogios, E. Dong, S. Bouatra, et al. 2009. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 37: D603-D610.
36. Wishart, D. S., D. Tzur, C. Knox, R. Eisner, A. C. Guo, N. Young, D. Cheng, K. Jewell, D. Arndt, S. Sawhney, et al. 2007. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35: D521-D526. (Pubitemid 46056263)